Total Visits

Views
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group Study137

Total Visits Per Month

October 2023November 2023December 2023January 2024February 2024March 2024April 2024
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group Study11101002

Top country views

Views
Poland64
United States54
Ireland12
India2
Slovenia2
China1
France1
Romania1

Top cities views

Views
Warsaw64
Dublin12
Louisville10
San Ramon8
Des Moines6
Boardman5
Fairfield5
Ann Arbor3
Ashburn3
Alexandria2